Starling Oncology, Inc. Finance Lease, Liability, Undiscounted Excess Amount
Starling Oncology, Inc. (STLN) had Finance Lease, Liability, Undiscounted Excess Amount of $1.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Leases
us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount · last filed 2026-08-06
- 2026-06-30: Finance Lease, Liability, Undiscounted Excess Amount $1.00K.
- 2026-03-31: Finance Lease, Liability, Undiscounted Excess Amount $3.00K.
- 2025-12-31: Finance Lease, Liability, Undiscounted Excess Amount $4.00K.
- 2025-09-30: Finance Lease, Liability, Undiscounted Excess Amount $5.00K.
| Period end | Finance Lease, Liability, Undiscounted Excess Amount |
|---|---|
| 2026-06-30 | $1.00K 10-Q · filed 2026-08-06 |
| 2026-03-31 | $3.00K 10-Q · filed 2026-05-07 |
| 2025-12-31 | $4.00K 10-K · filed 2026-03-12 |
| 2025-09-30 | $5.00K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $6.00K 10-Q · filed 2025-08-13 |
| 2025-03-31 | $7.00K 10-Q · filed 2025-05-14 |
| 2024-12-31 | $9.00K 10-K · filed 2025-03-26 |
| 2024-09-30 | $10.00K 10-Q · filed 2024-11-13 |
| 2024-06-30 | $12.00K 10-Q · filed 2024-08-13 |
| 2024-03-31 | $15.00K 10-Q · filed 2024-05-14 |
| 2023-12-31 | $18.00K 10-K · filed 2024-03-28 |
| 2023-09-30 | $20.00K 10-Q · filed 2023-11-08 |
| 2023-06-30 | $23.00K 10-Q · filed 2023-08-09 |
| 2023-03-31 | $26.00K 10-Q · filed 2023-05-10 |
| 2022-12-31 | $30.00K 10-K · filed 2023-03-16 |
| 2022-09-30 | $34.00K 10-Q · filed 2022-11-09 |
| 2022-06-30 | $6.00K 10-Q · filed 2022-08-09 |
| 2022-03-31 | $7.00K 10-Q · filed 2022-05-10 |